Effects of an anti-inflammatory peptide (antiflammin 2) on cell influx, eicosanoid biosynthesis and oedema formation by arachidonic acid and tetradecanoyl phorbol dermal application

This publication has 23 references indexed in Scilit:

• Time-course of phospholipase A2, eicosanoid release and cellular accumulation in rat immunological air pouch inflammation
  International Journal of Immunopharmacology, 1993
• Inhibition of pancreatic phospholipase A2 activity by uteroglobin and antiflammin peptides: Possible mechanism of action
  Life Sciences, 1991
• Antiflammin-2 (HDMNKVLDL) does not inhibit phospholipase A2 activities
  Inflammation Research, 1991
• ‘Antiflammins’: Two nonapeptide fragments of uteroglobin and lipocortin I have no phospholipase A₂ ‐inhibitory and anti‐inflammatory activity
  FEBS Letters, 1990
• Antiinflammatory peptides (antiflammins) inhibit synthesis of platelet-activating factor, neutrophil aggregation and chemotaxis, and intradermal inflammatory reactions.
  The Journal of Experimental Medicine, 1990
• Synthetic peptide from lipocortin I has no phospholipase A₂ inhibitory activity
  FEBS Letters, 1989
• Novel anti-inflammatory peptides from the region of highest similarity between uteroglobin and lipocortin I
  Nature, 1988
• Uteroglobin inhibits phospholipase A2 activity
  Life Sciences, 1986
• Measurement of Cutaneous Inflammation: Estimation of Neutrophil Content with an Enzyme Marker
  Journal of Investigative Dermatology, 1982
• Macrocortin: a polypeptide causing the anti-phospholipase effect of glucocorticoids
  Nature, 1980